Several biomarkers for diagnosis of<unk>  sclerosis, disease evolution and response to medication (current or expected) are under research. While most of them are still under research, there are some of them already well stablished: *oligoclonal bands: They present proteins that are in the CNS or in blood. Those that are in CNS but not in blood suggest a diagnosis of MS. *MRZ-Reaction: A polyspecific antiviral immune response against the viruses of measles, rubella and zoster found in 1992. In some reports the MRZR showed a lower sensitivity than OCB (70% vs. 100%), but a higher specificity (69% vs. 92%) for MS. *free light chains (FLC). Several authors have reported that they are comparable or even better than oligoclonal bands. They can be of several types like body fluid biomarkers, imaging biomarkers or genetic biomarkers. They are expected to play an important role in the near future of MS.
Multiple sclerosis biomarkers
Alzheimer's disease biomarkers
Multiple sclerosis functional composite
Charcot–Marie–Tooth disease classifications
Multiple sclerosis drug pipeline
Multiple sclerosis research
Amyotrophic lateral sclerosis research
Biochemistry of Alzheimer's disease